[The possible maternal risk of tocolytic therapy with fenoterol (partusisten) (author's transl)].
Report on two patients with postpartum pulmonary oedema and shock-syndrome subsequent to prepartum tocolytic therapy with Fenoterol in higher dosages. The possible pathogenetic interactions and the differential diagnosis of this status are discussed. Conclusions are drawn for the clinical use of tocolytic drugs.
D000328:Adult; D001344:Autopsy; D004983:Ethanolamines / Q000009:adverse effects*; D005260:Female; D005280:Fenoterol / Q000009:adverse effects*; D006801:Humans; D009205:Myocarditis / Q000150:complications; D007752:Obstetric Labor, Premature / Q000517:prevention & control; D011247:Pregnancy; D011644:Puerperal Disorders / Q000139:chemically induced*; D011654:Pulmonary Edema / Q000139:chemically induced* / Q000473:pathology; D012769:Shock / Q000139:chemically induced*
D004983:Ethanolamines; D005280:Fenoterol
Zum mütterlichen Risiko der medikamentösen Tokolyse mit Fenoterol (Partusisten).